Advertisement

Journal of Gastrointestinal Surgery

, Volume 19, Issue 1, pp 117–123 | Cite as

Surgical Resection Provides an Overall Survival Benefit for Patients with Small Pancreatic Neuroendocrine Tumors

  • Susan M. Sharpe
  • Haejin In
  • David J. Winchester
  • Mark S. Talamonti
  • Marshall S. BakerEmail author
2014 SSAT Plenary Presentation

Abstract

Background

The optimal management of small (≤2 cm) pancreatic neuroendocrine tumors (PNETs) remains controversial. We evaluated these tumors in the National Cancer Data Base (NCDB) to determine if resection provides a survival advantage over observation.

Methods

The NCDB was queried to identify patients with nonmetastatic PNETs ≤2 cm treated between 1998 and 2006. Kaplan-Meier survival estimates, stratified by grade and treatment type, evaluated the difference in 5-year overall survival (OS) between patients who underwent resection and observation. Multivariable Cox regression was used to determine the importance of resection in OS.

Results

Three hundred eighty patients met inclusion criteria. Eighty-one percent underwent resection; 19 % were observed. Five-year OS was 82.2 % for patients who underwent surgery and 34.3 % for those who were observed (p < 0.0001). When controlling for age, comorbidities, income, facility type, tumor size and location, grade, margin status, nodal status, surgical management, and nonsurgical therapy in the Cox model, observation [hazard ratio (HR) 2.80], poorly differentiated histology (HR 3.79), lymph node positivity (HR 2.01), and nonsurgical therapies (HR 2.23) were independently associated with an increase in risk of mortality (p < 0.01).

Conclusion

Patients with localized PNETs ≤2 cm had an overall survival advantage with resection compared to observation, independent of age, comorbidities, tumor grade, and treatment with nonsurgical therapies.

Keywords

Pancreas Neuroendocrine Tumor Surgery Survival 

Notes

References

  1. 1.
    Bettini R, Partelli S, Boninsegna L, Capelli P, Crippa S, Pederzoli P, Scarpa A, Falconi M. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery 2011;150:75–82.PubMedCrossRefGoogle Scholar
  2. 2.
    Franko J, Feng W, Yip L, Genovese E, Moser AJ. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients. Journal of Gastrointestinal Surgery 2010;14:541–548.PubMedCrossRefGoogle Scholar
  3. 3.
    Cherenfant J, Stocker SJ, Gage MK, Du H, Thurow TA, Odeleye M, Schimpke SW, Kaul KL, Hall CR, Lamzabi I, Gattuso P, Winchester DJ, Marsh RW, Roggin KK, Bentrem DJ, Baker MS, Prinz RA, Talamonti MS. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery 2013;154:785–791.PubMedCrossRefGoogle Scholar
  4. 4.
    Bilimoria KY, Talamonti MS, Tomlinson JS, Stewart AK, Winchester DP, Ko CY, Bentrem DJ. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: Analysis of 3851 patients. Annals of Surgery 2008;247:490–500.PubMedCrossRefGoogle Scholar
  5. 5.
    Haynes AB, Deshpande V, Ingkakul T, Vagefi PA, Szymonifka J, Thayer SP, Ferrone CR, Wargo JA, Warshaw AL, Fernandez-del Castillo C. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: Short-term and long-term patient outcomes. Archives of Surgery 2011;146:534–538.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Lee LC, Grant CS, Salomao DR, Fletcher JG, Takahashi N, Fidler JL, Levy MJ, Huebner M. Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): Role for nonoperative management. Surgery 2012;152:965–974.PubMedCrossRefGoogle Scholar
  7. 7.
    Gaujoux S, Partelli S, Maire F, D’Onofrio M, Larroque B, Tamburrino D, Sauvanet A, Falconi M, Ruszniewski P. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. Journal of Clinical Endocrinology and Metabolism 2013;98:4784–4789.PubMedCrossRefGoogle Scholar
  8. 8.
    Kooby DA, Gillespie TW, Liu Y, Byrd-Sellers J, Landry J, Bian J, Lipscomb J. Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: An appraisal of data from the National Cancer Data Base. Annals of Surgical Oncology 2013;20:3634–3642.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2014

Authors and Affiliations

  • Susan M. Sharpe
    • 1
  • Haejin In
    • 1
  • David J. Winchester
    • 2
    • 3
  • Mark S. Talamonti
    • 2
    • 3
  • Marshall S. Baker
    • 2
    • 3
    • 4
    Email author
  1. 1.Department of Surgery, Pritzker School of MedicineUniversity of ChicagoChicagoUSA
  2. 2.Department of SurgeryNorthShore University HealthSystemEvanstonUSA
  3. 3.Pritzker School of MedicineUniversity of ChicagoChicagoUSA
  4. 4.Evanston HospitalEvanstonUSA

Personalised recommendations